|
[1]
|
American Diabetes Association (2013) Diagnosis and Classification of Diabetes Mellitus. Diabetes Care, 36, S67-S74. http://dx.doi.org/10.2337/dc13-S067
|
|
[2]
|
American Diabetes Association (2011) Diabetes Statistics.
http://www.diabetes.org/diabetes-basics/diabetes-statistics/?loc=DropDownDB-stats
|
|
[3]
|
American Diabetes Association (2013) Executive Summary: Standards of Medical Care in Diabetes—2013. Diabetes Care, 36, S4-S10.
http://dx.doi.org/10.2337/dc13-S004
|
|
[4]
|
United States National Library of Medicine (2013) Dietary Supplements Labels and Database: Frequently Asked Questions.
http://dietarysupplements.nlm.nih.gov/dietary/faq.jsp#1
|
|
[5]
|
Nahin, R.L., Barnes, P.M., Stussman, B.J. and Bloom, B. (2009) Costs of Complementary and Alternative Medicine (CAM) and Frequency of Visits to CAM Practitioners: United States, 2007. National Health Statistics Reports, 18, 1-14.
|
|
[6]
|
Yeh, G.Y., Eisenberg, D.M., Davis, R.B. and Phillips, R.S. (2002) Use of Complementary and Alternative Medicine among Persons with Diabetes Mellitus: Results of a National Survey. American Journal of Public Health, 92, 1648-1652.
http://dx.doi.org/10.2105/AJPH.92.10.1648
|
|
[7]
|
Shah, S.N. and Ajmera, J. (1993) Newer Hypoglycaemic Agents—Its Relevance. Journal of the Association of Physicians of India, 41, 699.
|
|
[8]
|
Uusitupa, M., Siitonen, O., Savolainen, K., Silvasti, M., Penttilä, I. and Parviainen, M. (1989) Metabolic and Nutritional Effects of Long-Term Use of Guar Gum in the Treatment of Noninsulin-Dependent Diabetes of Poor Metabolic Control. The American Journal of Clinical Nutrition, 49, 345-351.
|
|
[9]
|
Van Duyn, M.A., Leo, T.A., McIvor, M.E., Behall, K.M., Michnowski, J.E. and Mendeloff, A.I. (1986) Nutritional Risk of High-Carbohydrate, Guar Gum Dietary Supplementation in Non-Insulin-Dependent Diabetes Mellitus. Diabetes Care, 9, 497-503.
http://dx.doi.org/10.2337/diacare.9.5.497
|
|
[10]
|
Russo, A., Stevens, J.E., Wilson, T., et al. (2003) Guar Attenuates Fall in Postprandial Blood Pressure and Slows Gastric Emptying of Oral Glucose in Type 2 Diabetes. Digestive Diseases and Sciences, 48, 1221-1229.
http://dx.doi.org/10.1023/A:1024182403984
|
|
[11]
|
Lewis, J.H. (1992) Esophageal and Small Bowel Obstruction from Guar Gum-Containing “Diet Pills”: Analysis of 26 Cases Reported to the Food and Drug Administration. The American Journal of Gastroenterology, 87, 1424-1428.
|
|
[12]
|
Beattie, V.A., Edwards, C.A., Hosker, J.P., Cullen, D.R., Ward, J.D. and Read, N.W. (1988) Does Adding Fibre to a Low Energy, High Carbohydrate, Low Fat Diet Confer Any Benefit to the Management of Newly Diagnosed Overweight Type II Diabetics? British Medical Journal (Clinical Research Ed.), 296, 1147-1149.
http://dx.doi.org/10.1136/bmj.296.6630.1147
|
|
[13]
|
Fuessl, H.S., Williams, G., Adrian, T.E. and Bloom, S.R. (1987) Guar Sprinkled on Food: Effect on Glycaemic Control, Plasma Lipids and Gut Hormones in Non-Insulin Dependent Diabetic Patients. Diabetic Medicine, 4, 463-468.
http://dx.doi.org/10.1111/j.1464-5491.1987.tb00910.x
|
|
[14]
|
Groop, P.H., Aro, A., Stenman, S. and Groop, L. (1993) Long-Term Effects of Guar Gum in Subjects with Non-Insulin-Dependent Diabetes Mellitus. The American Journal of Clinical Nutrition, 58, 513-518.
|
|
[15]
|
Kirsten, R., Heintz, B., Nelson, K., Oremek, G. and Speck, U. (1992) Influence of Two Guar Preparations on Glycosylated Hemoglobin, Total Cholesterol and Triglycerides in Patients with Diabetes Mellitus. International Journal of Clinical Pharmacology, Therapy, and Toxicology, 30, 582-586.
|
|
[16]
|
Wilson, J.A., Scott, M.M. and Gray, R.S. (1989) A Comparison of Metformin versus Guar in Combination with Sulphonylureas in the Treatment of Non Insulin Dependent Diabetes. Hormone and Metabolic Research, 21, 317-319.
http://dx.doi.org/10.1055/s-2007-1009224
|
|
[17]
|
Swaminathan, R. (2003) Magnesium Metabolism and Its Disorders. Clinical Biochemist Reviews, 24, 47-66.
|
|
[18]
|
de Lordes Lima, M., Cruz, T., Pousada, J.C., Rodrigues, L.E., Barbosa, K. and Canguçu, V. (1998) The Effect of Magnesium Supplementation in Increasing Doses on the Control of Type 2 Diabetes. Diabetes Care, 21, 682-686.
http://dx.doi.org/10.2337/diacare.21.5.682
|
|
[19]
|
Guerrero-Romero, F. and Rodríguez-Morán, M. (2002) Low Serum Magnesium Levels and Metabolic Syndrome. Acta Diabetologica, 39, 209-213.
http://dx.doi.org/10.1007/s005920200036
|
|
[20]
|
Kass, L., Weekes, J. and Carpenter, L. (2012) Effect of Magnesium Supplementation on Blood Pressure: A Meta-Analysis. European Journal of Clinical Nutrition, 66, 411-418.
http://dx.doi.org/10.1038/ejcn.2012.4
|
|
[21]
|
Birrer, R.B., Shallash, A.J. and Totten, V. (2002) Hypermagnesemia-Induced Fatality Following Epsom Salt Gargles. Journal of Emergency Medicine, 22, 185-188.
http://dx.doi.org/10.1016/S0736-4679(01)00462-0
|
|
[22]
|
Gullestad, L., Jacobsen, T. and Dolva, L.O. (1994) Effect of Magnesium Treatment on Glycemic Control and Metabolic Parameters in NIDDM Patients. Diabetes Care, 17, 460-461.
|
|
[23]
|
Lal, J., Vasudev, K., Kela, A.K. and Jain, S.K. (2003) Effect of Oral Magnesium Supplementation on the Lipid Profile and Blood Glucose of Patients with Type 2 Diabetes Mellitus. Journal of the Association of Physicians of India, 51, 37-42.
|
|
[24]
|
Paolisso, G., Scheen, A., Cozzolino, D., Di Maro, G., Varricchio, M., D’Onofrio, F. and Lefebvre, P.J. (1994) Changes in Glucose Turnover Parameters and Improvement of Glucose Oxidation after 4-Week Magnesium Administration in Elderly Noninsulin-Dependent (Type II) Diabetic Patients. Journal of Clinical Endocrinology & Metabolism, 78, 1510-1514.
http://dx.doi.org/10.1210/jcem.78.6.8200955
|
|
[25]
|
Purvis, J.R., Cummings, D.M., Landsman, P., et al. (1994) Effect of Oral Magnesium Supplementation on Selected Cardiovascular Risk Factors in Non-Insulin-Dependent Diabetics. Archives of Family Medicine, 3, 503-508.
http://dx.doi.org/10.1001/archfami.3.6.503
|
|
[26]
|
Rodríguez-Morán, M. and Guerrero-Romero, F. (2003) Oral Magnesium Supplementation Improves Insulin Sensitivity and Metabolic Control in Type 2 Diabetic Subjects: A Randomized Double-Blind Controlled Trial. Diabetes Care, 26, 1147-1152.
http://dx.doi.org/10.2337/diacare.26.4.1147
|
|
[27]
|
Yokota, K., Kato, M., Lister, F., Ii, H., Hayakawa, T., Kikuta, T., Kageyama, S. and Tajima, N. (2004) Clinical Efficacy of Magnesium Supplementation in Patients with Type 2 Diabetes. Journal of the American College of Nutrition, 23, 506S-509S.
http://dx.doi.org/10.1080/07315724.2004.10719390
|
|
[28]
|
Englyst, H.N. and Cummings, J.H. (1985) Digestion of the Polysaccharides of Some Cereal Foods in the Human Small Intestine. American Journal of Clinical Nutrition, 42, 778-787.
|
|
[29]
|
Cooper, S.G. and Tracey, E.J. (1989) Small-Bowel Obstruction Caused by Oat-Bran Bezoar. New England Journal of Medicine, 320, 1148-1149.
http://dx.doi.org/10.1056/NEJM198904273201718
|
|
[30]
|
Pick, M.E., Hawrysh, Z.J., Gee, M.I., Toth, E., Garg, M.L. and Hardin, R.T. (1996) Oat Bran Concentrate Bread Products Improve Long-Term Control of Diabetes: A Pilot Study. Journal of the American Dietetic Association, 96, 1254-1261.
http://dx.doi.org/10.1016/S0002-8223(96)00329-X
|
|
[31]
|
Tapola, N., Karvonen, H., Niskanen, L., Mikola, M. and Sarkkinen, E. (2005) Glycemic Responses of Oat Bran Products in Type 2 Diabetic Patients. Nutrition, Metabolism & Cardiovascular Diseases, 15, 255-261.
http://dx.doi.org/10.1016/j.numecd.2004.09.003
|
|
[32]
|
Sierra, M., García, J.J., Fernández, N., Diez, M.J. and Calle, A.P. (2002) Therapeutic Effects of Psyllium in Type 2 Diabetic Patients. European Journal of Clinical Nutrition, 56, 830-842.
http://dx.doi.org/10.1038/sj.ejcn.1601398
|
|
[33]
|
Ziai, S.A., Larijani, B., Akhoondzadeh, S., et al. (2005) Psyllium Decreased Serum Glucose and Glycosylated Hemoglobin Significantly in Diabetic Outpatients. Journal of Ethnopharmacology, 102, 202-207.
http://dx.doi.org/10.1016/j.jep.2005.06.042
|
|
[34]
|
Anderson, J.W., Allgood, L.D., Turner, J., Oeltgen, P.R. and Daggy, B.P. (1999) Effects of Psyllium on Glucose and Serum Lipid Responses in Men with Type 2 Diabetes and Hypercholesterolemia. American Journal of Clinical Nutrition, 70, 466-473.
|
|
[35]
|
Sartore, G., Reitano, R., Barison, A., Magnanini, P., Cosma, C., Burlina, S., Manzato, E., Fedele, D. and Lapolla, A. (2009) The Effects of Psyllium on Lipoproteins in Type II Diabetic Patients. European Journal of Clinical Nutrition, 63, 1269-1271.
http://dx.doi.org/10.1038/ejcn.2009.60
|
|
[36]
|
Barnes, J., Anderson, L. and Phillips, D. (2007) Herbal Medicine. 3rd Edition, the Pharmaceutical Press, London.
|
|
[37]
|
US Food and Drug Administration (2013) Guidance for Industry: A Food Labeling Guide (11. Appendix C: Health Claims). http://www.fda.gov/Food/GuidanceRegulation/GuidanceDoc
umentsRegulatoryInformation/LabelingNutrition/ucm064919.htm
|
|
[38]
|
Pastors, J.G., Blaisdell, P.W., Balm, T.K., Asplin, C.M. and Pohl, S.L. (1991) Psyllium Fiber Reduces Rise in Postprandial Glucose and Insulin Concentrations in Patients with Non-Insulin-Dependent Diabetes. American Journal of Clinical Nutrition, 53, 1431-1435.
|
|
[39]
|
Rodríguez-Morán, M., Guerrero-Romero, F. and Lazcano-Burciaga, G. (1998) Lipid- and Glucose-Lowering Efficacy of Plantago Psyllium in Type II Diabetes. Journal of Diabetes and Its Complications, 12, 273-278.
http://dx.doi.org/10.1016/S1056-8727(98)00003-8
|
|
[40]
|
González, S., Jayagopal, V., Kilpatrick, E.S., Chapman, T. and Atkin, S.L. (2007) Effects of Isoflavone Dietary Supplementation on Cardiovascular Risk Factors in Type 2 Diabetes. Diabetes Care, 30, 1871-1873.
http://dx.doi.org/10.2337/dc06-1814
|
|
[41]
|
Jayagopal, V., Albertazzi, P., Kilpatrick, E.S., et al. (2002) Beneficial Effects of Soy Phytoestrogen Intake in Postmenopausal Women with Type 2 Diabetes. Diabetes Care, 25, 1709-1714. http://dx.doi.org/10.2337/diacare.25.10.1709
|
|
[42]
|
RisticMedic, D., Ristic, V., Arsic, A., et al. (2006) Effects of Soybean D-LeciVita Product on Serum Lipids and Fatty Acid Composition in Type 2 Diabetic Patients with Hyperlipidemia. Nutrition, Metabolism & Cardiovascular Diseases, 16, 395-404.
http://dx.doi.org/10.1016/j.numecd.2005.06.008
|
|
[43]
|
Deplancke, B. and Gaskins, H.R. (2001) Microbial Modulation of Innate Defense: Goblet Cells and the Intestinal Mucus Layer. American Journal of Clinical Nutrition, 73, 1131S-1141S.
|
|
[44]
|
Unfer, V., Casini, M.L., Costabile, L., Mignosa, M., Gerli, S. and Di Renzo, G.C. (2004) Endometrial Effects of Long-Term Treatment with Phytoestrogens: A Randomized, Double-Blind, Placebo-Controlled Study. Fertility and Sterility, 82, 145-148.
http://dx.doi.org/10.1016/j.fertnstert.2003.11.041
|
|
[45]
|
Anderson, J.W., Blake, J.E., Turner, J. and Smith, B.M. (1998) Effects of Soy Protein on Renal Function and Proteinuria in Patients with Type 2 Diabetes. American Journal of Clinical Nutrition, 68,1347S-1353S.
|
|
[46]
|
Azadbakht, L., Atabak, S. and Esmaillzadeh, A. (2008) Soy Protein Intake, Cardiorenal Indices, and C-Reactive Protein in Type 2 Diabetes with Nephropathy: A Longitudinal Randomized Clinical Trial. Diabetes Care, 31, 648-654.
http://dx.doi.org/10.2337/dc07-2065
|
|
[47]
|
Hermansen, K., Søndergaard, M., Høie, L., Carstensen, M. and Brock, B. (2001) Beneficial Effects of a Soy-Based Dietary Supplement on Lipid Levels and Cardiovascular Risk Markers in Type 2 Diabetic Subjects. Diabetes Care, 24, 228-233.
http://dx.doi.org/10.2337/diacare.24.2.228
|
|
[48]
|
Kwak, J.H., Lee, J.H., Ahn, C.W., et al. (2010) Black Soy Peptide Supplementation Improves Glucose Control in Subjects with Prediabetes and Newly Diagnosed Type 2 Diabetes Mellitus. Journal of Medicinal Food, 13, 1307-1312.
http://dx.doi.org/10.1089/jmf.2010.1075
|
|
[49]
|
Teixeira, S.R., Tappenden, K.A., Carson, L., Jones, R., Prabhudesai, M., Marshall, W.P. and Erdman Jr., J.W. (2004) Isolated Soy Protein Consumption Reduces Urinary Albumin Excretion and Improves the Serum Lipid Profile in Men with Type 2 Diabetes Mellitus and Nephropathy. Journal of Nutrition, 134, 1874-1880.
|
|
[50]
|
Tsai, A.C., Vinik, A.I., Lasichak, A. and Lo, G.S. (1987) Effects of Soy Polysaccharide on Postprandial Plasma Glucose, Insulin, Glucagon, Pancreatic Polypeptide, Somatostatin, and Triglyceride in Obese Diabetic Patients. American Journal of Clinical Nutrition, 45, 596-601.
|
|
[51]
|
Kang, M.J., Kim, J.I., Yoon, S.Y., Kim, J.C. and Cha, I.J. (2006) Pinitol from Soybeans Reduces Postprandial Blood Glucose in Patients with Type 2 Diabetes Mellitus. Journal of Medicinal Food, 9, 182-186.
http://dx.doi.org/10.1089/jmf.2006.9.182
|
|
[52]
|
American Diabetes Association (2013) Understanding Carbohydrates.
http://www.diabetes.org/food-and-fitness/food/what-can-i-eat/carbohydrates.html
|